Indefinite Delivery Contract SPE2DR25D9231
Award Date 9/1/25
Last Date to Order 12/31/36
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a single-award Indefinite Delivery Contract (IDC) valued at $5.0 million by the Defense Logistics Agency (DLA) on August 1, 2025, with an ultimate completion date of December 31, 2036. The contract, designated SPE2DX under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency on November 13, 2025, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract, designated SPE2DX, carries a ceiling value of $5.0 million and extends through December 31, 2036, encompassing a 30-month base period with three 30-month...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain division on April 2, 2025, with a ceiling value of $19,999,999 and an ultimate completion date of March 6, 2038. This contract represents DMS Pharmaceutical Group's engagement as a pharmaceutical prime vendor under the Pharmaceutical Prime Vendor Global Program Generation...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (DLA) Troop Support on March 7, 2025, with an ultimate completion date of March 6, 2035. The contract establishes DMS as a Pharmaceutical Prime Vendor providing comprehensive pharmaceutical support to Department of Defense customers globally under the Prime Vendor Fleet program. The contractor will supply an extensive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a single-award Indefinite Delivery Contract valued at $20,000,000 with an ultimate completion date of March 6, 2035, awarded by the Medical Supply Chain, a Defense agency component, on July 1, 2025. The contract establishes DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, authorized to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply...
- The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The IDC has a ceiling value of $499,999,999 and is valid through November 2026. Under this contract, DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical...
- The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide. The IDC, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of...